Radiofrequency ablation and immunostimulant OK-432: combination therapy enhances systemic antitumor immunity for treatment of VX2 lung tumors in rabbits (Q39188783)

From Wikidata
Jump to navigation Jump to search
scientific article published on 25 February 2013
edit
Language Label Description Also known as
English
Radiofrequency ablation and immunostimulant OK-432: combination therapy enhances systemic antitumor immunity for treatment of VX2 lung tumors in rabbits
scientific article published on 25 February 2013

    Statements

    Radiofrequency ablation and immunostimulant OK-432: combination therapy enhances systemic antitumor immunity for treatment of VX2 lung tumors in rabbits (English)
    Shinichi Hamamoto
    Tomohisa Okuma
    Akira Yamamoto
    Ken Kageyama
    Toru Takeshita
    Yukimasa Sakai
    Norifumi Nishida
    Toshiyuki Matsuoka
    Yukio Miki
    25 February 2013
    405-413

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit